Search Results 411-420 of 17470 for Vitiligo

  1. Improving Access to Care Through the Establishment of a Local, Teledermatology Network - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  3. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients - Mayo Clinic

    About this study. This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of ...

  4. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. Participation ...

  5. Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) - Mayo Clinic

    Skin hypopigmentation (vitiligo). Has a history of severe hypersensitivity reactions to either the drug substances or inactive ingredients (including but ...

  6. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  7. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

    ... vitiligo, psoriasis) not requiring systemic treatment. Significant chronic or acute infectionsincluding infection with mpox and SARS-CoV-2 (COVID19) PCR ...

  8. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Skin diseases not requiring systemic treatment (e.g., vitiligo, psoriasis, or alopecia). Any other disease that is not expected to recur in the absence of ...

  9. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

    Toxicity persisting from previous anti-cancer therapy of ≥ Grade 2 (except for non-clinically significant toxicities; e.g., alopecia, vitiligo). Subjects ...

  10. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.